Related Experiment Video
Updated: Sep 26, 2025

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
Published on: August 16, 2010
Recent Advances in Senotherapeutics Delivery
Ji Young Choi1,2, Samantha F Yee1, Tzvetelina Tchangalova1
1Tissue Engineering and Biomaterials Laboratory, Fischell Department of Bioengineering, A. James Clark School of Engineering, University of Maryland, College Park, Maryland, USA.
Abstract:
Accumulation of senescent cells (SnCs) in various tissue types has been connected to an occurrence of different age-related diseases that are indicated by its own tissue-specific hallmarks. Discovery of novel senolytic compounds that target major cellular mechanisms to inhibit the level of SnCs within the specific tissues or organs has been an emerging field in the age-related disease research. Although the positive effect of senolytics in global suppression of SnCs has been well studied in the past, effective tissue-specific delivery strategy of senotherapeutics before clinical application needs to be further investigated. In this review, we discuss the latest biological insights to currently available senotherapeutic options and explore the impactful in vitro tissue-engineered models possibly as a testbed for replicable testing of tissue-specific potency of senolytics. Impact statement Senotherapy, the inhibition of accumulated senescent cells, is recognized as a significantly impactful way to treat various human diseases. However, there is limited comprehensive reviews on this topic. This review provides in-depth discussion on diverse delivery strategies of senolytic agents and latest updates on a novel senotherapeutic research.
Insights
Senotherapy clears senescent cells (SnCs) to combat age-related diseases. This review explores senolytic delivery strategies and tissue-engineered models for effective senotherapeutic development.
Area of Science:
- Gerontology and Cellular Biology
- Biomedical Engineering
- Pharmacology
Background:
- Accumulated senescent cells (SnCs) contribute to age-related diseases.
- Senolytics target SnCs, but tissue-specific delivery remains a challenge.
- Senotherapy offers a promising therapeutic avenue for various human diseases.
Purpose of the Study:
- To review current senotherapeutic options and biological insights.
- To explore tissue-engineered models for senolytic testing.
- To discuss effective tissue-specific delivery strategies for senotherapeutics.
Main Methods:
- Literature review of senolytic compounds and delivery strategies.
- Analysis of current senotherapeutic research and biological insights.
- Exploration of in vitro tissue-engineered models for senolytic potency testing.
Main Results:
- Senolytics show promise in reducing SnCs globally.
- Effective tissue-specific delivery of senotherapeutics requires further investigation.
- In vitro tissue-engineered models offer a platform for testing senolytic efficacy.
Conclusions:
- Senotherapy is a key strategy for treating age-related diseases.
- Developing targeted senolytic delivery systems is crucial for clinical translation.
- Tissue-engineered models can accelerate the validation of novel senotherapeutics.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

